首页> 外文期刊>Bone marrow transplantation >Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT.
【24h】

Little impact of donor/recipient major mismatch for neutrophil-specific antigen NA2 on neutrophil recovery after allogeneic SCT.

机译:中性粒细胞特异性抗原NA2的供体/受体主要错配对异基因SCT后中性粒细胞恢复的影响很小。

获取原文
获取原文并翻译 | 示例
       

摘要

The Fcgamma receptor IIIb (FcgammaRIIIb), a receptor for the Fcgamma region of IgG, is specifically expressed on neutrophils. It has two allelic polymorphisms, NA1 and NA2, which are highly immunogenic and act as targets in alloimmune or autoimmune neutropenia. Thus, neutrophil antigens (NA) compatibility of donor/recipient pairs might be expected to affect the engraftment of neutrophils after allogeneic SCT (allo-SCT). Here, the impact of NA compatibility of 17 patients and their donors undergoing allo-SCT with a myeloablative regimen was determined. Leukocyte depletion filters were used for all transfusions before and post-SCT; most patients received G-CSF after transplant. Major mismatches for NA1 and NA2 were present in 1 and 7 patient/donor pairs, respectively. These eight patients receiving NA major-mismatched allo-SCT were compared with nine patients who received NA compatible allo-SCT. Engraftment of neutrophils and the incidence of post-engraftment neutropenia were found to be identical in thetwo groups. Despite the limitations in statistical power because of the small number of patients analyzed, these observations suggest that the major mismatching for NA2 antigen has little impact on the engraftment of neutrophils after myeloablative allo-SCT, at least in patients transfused using leukocyte depletion filters and receiving G-CSF after transplantation.
机译:Fcgamma受体IIIb(FcgammaRIIIb)是IgG Fcgamma区域的受体,在嗜中性粒细胞上特异性表达。它具有两个等位基因多态性,NA1和NA2,具有高度免疫原性,可作为同种免疫或自身免疫性中性粒细胞减少症的靶标。因此,可以预期供体/受体对的嗜中性粒细胞抗原(NA)相容性将影响同种异体SCT(allo-SCT)后嗜中性粒细胞的植入。在这里,确定了17名患者及其接受异体SCT的骨髓移植方案供体的NA相容性的影响。 SCT之前和之后的所有输注均使用白细胞耗竭过滤器。大多数患者在移植后接受了G-CSF。 NA1和NA2的主要错配分别存在于1和7对患者/供体中。将这8名接受NA严重不匹配的allo-SCT的患者与9名接受NA兼容的allo-SCT的患者进行比较。两组发现嗜中性粒细胞的植入和植入后中性粒细胞减少的发生率是相同的。尽管由于分析的患者数量少,统计能力受到限制,但这些观察结果表明,至少在使用白细胞耗竭滤器输注并接受抗凝治疗的患者中,NA2抗原的主要错配对嗜中性白细胞的植入几乎没有影响。移植后G-CSF。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号